Shankar Duraiswamy represents clients in high-stakes, complex litigation matters, particularly those involving products liability, mass torts, and class action claims.
Shankar is a highly effective advocate with a demonstrated record of success at all stages of litigation. In the past three years, he has secured case-dispositive rulings in more than a half dozen courts, including in two bench trials at which he served as lead counsel, a string of summary judgment victories, and two successful preliminary injunction motions.
Shankar has especially broad experience representing clients in the life sciences industry, combining his versatile litigation skills with deep industry knowledge. He has defended several companies against claims alleging product and warning defects in FDA-approved medications and devices. He also represents and advises pharmaceutical manufacturers on disputes related to prescription drug pricing, reimbursement, and access.
Shankar’s experience extends to other industries, where he has led the defense of some of the largest mass torts in the country, including a sprawling multi-jurisdictional litigation arising out of the largest automotive recall in history and a series of U.S. tort claims arising out of a foreign conflict zone.
Drawing on his industry and legal expertise, Shankar routinely advises clients in the life sciences, transportation, technology, and consumer products industries on product safety issues, and related litigation risks. Most recently, he has counseled several companies on the development and distribution of products and technologies to respond to the COVID-19 pandemic.
Back
